Periodic Reporting for period 1 - MetaIron (Targeting Mfrn2 to Inhibit Metastatic Cancers)

The majority of cancer patients dies due to metastasis formation in distant organs. To date, we unfortunately largely lack effective therapies for preventing or treating an already developed metastatic disease. The effect of this lack of treatment options against metastatic...